SciELO - Scientific Electronic Library Online

 
vol.138 número5Indicaciones de cirugía antirreflujo: ¿Buenos y malos candidatos para la cirugía? Revisión bibliográfica y experiencia personalParticipación del sistema endocanabinoide en el desarrollo de obesidad índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Revista médica de Chile

versión impresa ISSN 0034-9887

Resumen

VALLE, JOSÉ MANUEL; GONZALEZ-BARCALA, FRANCISCO JAVIER; ALVAREZ-DOBANO, JOSÉ MANUEL  y  VALDES C, LUIS. Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease. Rev. méd. Chile [online]. 2010, vol.138, n.5, pp. 612-620. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872010000500013.

Invasive pulmonary aspergillosis (IPA) is a severe disease, specially among immunocompromised patients. Its frequency increases in other patients such as those with Chronic Obstructive Pulmonary Disease (COPD), mainly when steroids are prescribed. The most common form of presentation is a respiratory tract infection with poor response to antimicrobial treatment. The delay in its diagnosis is one of the main causes of its high lethality. Once suspected, respiratory secretion cultures, chest X ray examination and computed tomography should be obtained and galactomannan, a marker of hematogenous dissemination of the microorganism, should be determined. Although the repeated isolation of Aspergillus spp is suggestive of invasive disease, the definitive diagnosis requires cytopathological confirmation. Further studies should be performed in these patients, since the available information was obtained from the observations made in immunocompromised patients, and may not be applicable accurately to API among COPD patients.

Palabras clave : Aspergillosis; Chronic obstructive; Immunity; Pulmonary disease.

        · texto en Español     · pdf en Español